Literature DB >> 4275492

[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].

W Birkmayer, W Linauer, M Mentasti, P Riederer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4275492

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


× No keyword cloud information.
  4 in total

1.  Nucleus ruber and L-dopa psychosis: biochemical post-mortem findings.

Authors:  W Birkmayer; W Danielczyk; E Neumayer; P Riederer
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

2.  L-dopa and (-)-deprenil in the treatment of Parkinson's disease: a long-term study [proceedings].

Authors:  L Ambrozi; W Birkmayer; P Riederer; M B Youdim
Journal:  Br J Pharmacol       Date:  1976-11       Impact factor: 8.739

Review 3.  Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 4.  Patterns and Determinants of Prescribing for Parkinson's Disease: A Systematic Literature Review.

Authors:  Khalid Orayj; Emma Lane
Journal:  Parkinsons Dis       Date:  2019-11-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.